IL19 and psoriasis: Importantly, our research shows that the IL-19 results obtained in psoriasis are replicable in atopic dermatitis, a common and relapsing inflammatory skin disease (with less defined skin lesions than psoriatic plaques) affecting a wide range of age groups with high global prevalence10–12.